Learn how bacteriostatic water with benzyl alcohol supports peptide reconstitution, what DINs and COAs verify, and why infants and IV use require caution.

Human evidence for sermorelin benefits is strongest for GH and IGF-1 changes; sleep gains lack support. Learn what trials measured and when effects appeared.

Calculate DSIP concentration, convert syringe units to micrograms, and compare community reports with historical IV research and Health Canada guidance.

Compare commonly cited IGF-1 LR3 dosing ranges with the limits of the evidence, reconstitution math, glucose risks, and Pure Peptide’s COA support.

Compare systemic copper peptides with retinol by route and human evidence, then check Canadian authorization before buying injectable products.

Compare how Selank and Semax affect different pathways, what human fMRI and stroke studies show, and why peptide purity and certificates of analysis matter.

Evidence-first TB-500 dosage in Canada: 4–8 mg loading and 2–2.5 mg maintenance explained, with COA checks, reconstitution math, and injection safety steps.

Evidence-first review of peptides and liver enzymes: how GLP-1 drugs lower ALT in fatty liver, why hepatoprotective peptides remain preclinical, and how…

Lab cold chain playbook for peptides. Choose product-specific pack outs, use ±0.5°C monitoring, document excursions, and let vials equilibrate before…

Lab focused explainer for researchers. See why an LC with UV 98.37% assay fell to 89.636% by mass balance and which CoA data to request.